23 machine-learning "https:" "https:" "CMU Portugal Program FCT" PhD positions at Monash University
Sort by
Refine Your Search
-
statement of interest Academic transcript Applications Close: Sunday 1 March 2026, 11:55pm AEDT Minimum entry requirements: https://www.monash.edu/admissions/entry-requirements/minimum Research webpages
-
" "Machine-learning-based imaging processing" webpage For further details or alternative opportunities, please contact: haoran.ren@monash.edu.
-
will receive a Research Living Allowance, at current value of $36,063AUD per annum 2025 full-time rate (tax-free stipend), indexed plus allowances as per RTP stipend scholarship conditions at: https
-
Research Living Allowance, at current value of $36,063AUD per annum 2025 full-time rate (tax-free stipend), indexed plus allowances as per RTP stipend scholarship conditions at: https://www.monash.edu
-
partner for businesses that keep Australia Truckin’, Shippin’, and Diggin’. As part of this scholarship, the PhD student will lead the expansion of the Driver Health Survey (https://drivinghealth.net/) , a
-
they fulfil the criteria for Masters by Research & PhD admission at Monash University. Details of the relevant requirements are available at https://www.monash.edu/engineering/future-students/graduate-research
-
requirements are available at https://www.monash.edu/engineering/future-students/graduate-research/how-to-apply Your application will be looked upon favourably if you: Graduated in the top 10% of your year level
-
new x-ray imaging techniques from the synchrotron to the laboratory Transforming breast cancer imaging with x-ray phase contrast Webpage: https://xrayimagingmonash.wordpress.com/ For further details
-
awardee. The Opportunity Generative artificial intelligence is a significant and highly visible use of machine learning which has become commonplace in a matter of a few short years. Without common
-
applicant will generate high-impact research by applying state-of-the-art deep learning, molecular modelling, and GPCR pharmacology to accelerate drug discovery for dementia treatment in postmenopausal women